Heartland Sneak Peek: HME Industry SWOT Analysis

Published in Government Relations on April 22, 2022

By Craig Douglas, Vice President, Payer and Member Relations, VGM Government Relations

The types and quantity of changes that have occurred within our industry over the past two years are unprecedented, and the majority of them have been driven by the COVID-19 pandemic. Some changes are legislative, some are regulatory, while others are payer policy/reimbursement related. Regardless of the type of change, they all impact your overall business strategy in some manner. These changes have made a profound impact on the DMEPOS industry as a whole, and most likely on your individual business as well. 

In the last 2 years, we’ve seen a Medicare competitive bid program that, for all intents and purposes, didn’t really happen for most of you, increased demand for certain products, policy changes from both CMS and private payers, reimbursement changes, supply chain issues, and product recalls that have impacted many DMEPOS providers.

From a cost perspective, several manufacturers have implemented either temporary surcharges or permanent price increases. These price increases are not limited to just a few manufacturers or a few products, but rather impact a large percentage of commonly requested DME product categories. In addition to the product cost changes, there have also been sharp increases in labor, shipping, fuel, and other overhead costs. There have also been new costs that weren’t there before, or that were previously minimal but are now much more substantial, such as PPE, temperature scanners, plastic barriers in the office, etc.

On the flip side of that, there have also been changes on the reimbursement side of things for many providers. Government program money (think Paycheck Protection Program, HHS Provider Relief Fund, etc.), as well as price increases from Medicare/Medicaid/private payers which helped offset some of the price increases providers were experiencing. Was there enough assistance? Was there too much? Many of those pricing changes are temporary, and there is still quite a bit of uncertainty surrounding the long-term reimbursement direction from the industry’s largest payer, CMS.

With all that has happened and that is yet to come, you may feel like you have more questions than answers in terms of what this looks like when ALL the dust settles.

Heartland LogoAt this year’s Heartland Conference, please join Craig Douglas, Ronda Buhrmester, Mark Higley, and John Gallagher from VGM as they discuss these topics, answer questions, and propose best practices and potential solutions to help your business thrive. Learn more and register at vgmheartland.com.   


TAGS

  1. billing & reimbursement
  2. cms
  3. heartland
  4. vgm government

From Our Experts

Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies. Gov't Shutdown & Telehealth Flexibility Expiration thumbnail Gov't Shutdown & Telehealth Flexibility Expiration September 30 represents an important date for HME providers for two reasons: 1) The potential of a government shutdown and how that affects HHS and CMS, and 2) the expiration of Telehealth Flexibilities unless a Continuing Resolution (CR) is agreed upon in time. Josh Turek Visits VGM to Champion Accessibility & Advocacy thumbnail Josh Turek Visits VGM to Champion Accessibility & Advocacy Waterloo, IA — On Monday, VGM Group hosted the first of our “Meet The Candidate” forums by welcoming Iowa State Representative Josh Turek, a Democratic candidate for the U.S. Senate seat soon to be vacated by Senator Joni Ernst. VGM & NCART Rally in D.C. to Defend CRT & HME Access thumbnail VGM & NCART Rally in D.C. to Defend CRT & HME Access Washington, D.C. – September 2025 — A powerful few days of advocacy wrapped up in the nation's capital as representatives from VGM Group, NCART, AAHomecare, and other key stakeholders in the Complex Rehab Technology (CRT) and Home Medical Equipment (HME) industries met with lawmakers to address urgent policy concerns. Igniting Champions Of Change During August Recess thumbnail Igniting Champions Of Change During August Recess This August recess, DME suppliers across the country seized the opportunity to engage with lawmakers and advocate for critical DMEPOS legislation. Their efforts are helping to build momentum and expand the network of congressional supporters. You Got The Contract! ...Now What?! Part 3: Contract Implementation thumbnail You Got The Contract! ...Now What?! Part 3: Contract Implementation Contract Implementation: Turning Agreements Into Revenue  Securing a contract is worth celebrating—but what happens next is just as critical. Do you have a structured process for implementation, or does the contract sit in your inbox waiting for an issue to arise? A robust implementation workflow is essential to ensure accurate and timely reimbursement and avoid preventable denials.